The Pharmacodynamic Effects of a Lower-Lipid Emulsion of Propofol: A Comparison with the Standard Propofol Emulsion
Authors:
- 1 March 2004
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 98 (3) , 687-691
Abstract
Using a randomized, double-blind protocol design, we compared a new lower-lipid emulsion of propofol (Ampofol®) containing propofol 1%, soybean oil 5%, and egg lecithin 0.6% with the most commonly used formulation of propofol (Diprivan®) with respect to onset of action and recovery profiles, as wellKeywords
This publication has 8 references indexed in Scilit:
- ALTERED Ca2+ CYCLING IN RAT HEART DURING SPESISAnesthesiology, 2003
- Pharmacodynamics and Pharmacokinetics of Propofol in a Medium-Chain Triglyceride EmulsionAnesthesiology, 2002
- Propofol in a Medium- and Long-Chain Triglyceride Emulsion: Pharmacological Characteristics and Potential Beneficial EffectsAnesthesia & Analgesia, 2002
- Propofol in an Emulsion of Long- and Medium-Chain Triglycerides: The Effect on PainAnesthesia & Analgesia, 2001
- Bisulfite-Containing Propofol: Is it a Cost-Effective Alternative to Diprivan™ for Induction of Anesthesia?Anesthesia & Analgesia, 2000
- Pharmaceutical and antimicrobial differences between propofol emulsion productsAmerican Journal of Health-System Pharmacy, 2000
- Lipid deposition during the long-term infusion of propofolCritical Care Medicine, 1995
- PropofolDrugs, 1995